Enhanced production of interleukin-1 and tumor necrosis factor alpha by cultured peripheral blood monocytes from patients with scleroderma. 1990

H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
Second Department of Internal Medicine, Kyoto University Medical School, Japan.

Cultured peripheral blood mononuclear cells from 20 patients with scleroderma were shown to produce high levels of interleukin-1 alpha, interleukin-1 beta, and tumor necrosis factor alpha. There were positive correlations between the production of these 3 molecules. Purified monocytes from these patients produced much more tumor necrosis factor alpha than did those from normal subjects, even without lipopolysaccharide stimulation. These results show the hyperactivity of monocytes from scleroderma patients.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015592 Immunoradiometric Assay Form of radioimmunoassay in which excess specific labeled antibody is added directly to the test antigen being measured. Assay, Immunoradiometric,Assays, Immunoradiometric,Immunoradiometric Assays

Related Publications

H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
January 1992, International journal of immunopharmacology,
H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
August 2000, Immunopharmacology and immunotoxicology,
H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
December 1992, Kekkaku : [Tuberculosis],
H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
July 1988, Journal of immunology (Baltimore, Md. : 1950),
H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
June 1995, Nihon Kyobu Shikkan Gakkai zasshi,
H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
January 1994, Neoplasma,
H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
July 1993, The Journal of investigative dermatology,
H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
July 1988, Journal of clinical & laboratory immunology,
H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
July 1990, Journal of periodontal research,
H Umehara, and S Kumagai, and M Murakami, and T Suginoshita, and K Tanaka, and S Hashida, and E Ishikawa, and H Imura
October 1990, Infection and immunity,
Copied contents to your clipboard!